Article: InforMedix CEO Highlights Technological Advancements at Phase IV Clinical Trials Conference.

Business Editors/Health/Medical Writers

BIOWIRE2K

Phase IV Clinical Trials Conference

ROCKVILLE, Md.--(BUSINESS WIRE)--Jan. 12, 2004

InforMedix, Inc. (OTCBB:IFMX) announced today that Bruce A. Kehr, M.D., chairman and CEO of InforMedix, is a featured speaker in a session entitled, "Employing Technology to Enhance Phase IV Procedures," at the Phase IV Clinical Trials Conference in Philadelphia, PA. During this session tomorrow, Dr. Kehr will present his talk entitled, "Patient Compliance Strategies that Enhance Clinical Trials and Post-Market Outcomes." The data will include information on how the Company's Med-eMonitor System(TM) ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!